Literature DB >> 28418469

Management of Helicobacter pylori Infection.

Robert T Kavitt1, Adam S Cifu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28418469     DOI： 10.1001/jama.2017.1949

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.

Authors:  C Prakash Gyawali
Journal:  Curr Gastroenterol Rep       Date:  2017-09

2.  Helicobacter pylori Regulates the Apoptosis of Human Megakaryocyte Cells via NF-κB/IL-17 Signaling.

Authors:  Huyi Lei; Yongyong Ma; Jie Tan; Qifa Liu
Journal:  Onco Targets Ther       Date:  2021-03-19       Impact factor: 4.147

Review 3.  Current Status of the Third-Line Helicobacter pylori Eradication.

Authors:  Jae Ho Choi; Young Joo Yang; Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  Gastroenterol Res Pract       Date:  2018-05-02       Impact factor: 2.260

4.  Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea.

Authors:  Beom Jin Kim; Hyuk Lee; Yong Chan Lee; Seong Woo Jeon; Gwang Ha Kim; Hyun-Soo Kim; Jae Kyu Sung; Dong Ho Lee; Heung Up Kim; Moo In Park; Il Ju Choi; Soon Man Yoon; Sang Wook Kim; Gwang Ho Baik; Ju Yup Lee; Jin Il Kim; Sang Gyun Kim; Jayoun Kim; Joongyup Lee; Jae Gyu Kim; Jae J Kim
Journal:  Gut Liver       Date:  2019-09-15       Impact factor: 4.519

5.  The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia.

Authors:  Yazed AlRuthia; Majid A Almadi; Sadeem Alqahtani; Hala Alrasheed; Mohammad Al-Owairdhi; Fahad Alsohaibani
Journal:  Saudi J Gastroenterol       Date:  2021 Jul-Aug       Impact factor: 2.485
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.